Fetal balloon trial aims to save babies with rare birth defect
NCT ID NCT07187206
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 3 trial tests a procedure called FETO, where a balloon is placed in the windpipe of a fetus to help lungs grow. It is for pregnant women carrying a baby with severe congenital diaphragmatic hernia, a condition where the diaphragm has a hole and organs move into the chest. The study will compare outcomes with standard care to see if FETO improves survival and lung growth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fetal Endoluminal Tracheal Occlusion (FETO) balloon device
- What this could lead to
- If successful, FETO could improve lung growth and survival for babies with severe congenital diaphragmatic hernia, offering a new standard of care.
- What could go wrong
- This is an invasive fetal procedure with risks to both mother and baby. The trial is still recruiting and results are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL DIAPHRAGMATIC HERNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital Medical Center (CCHMC)
RECRUITINGCincinnati, Ohio, 45229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scoliosis's hidden toll: can we predict lung and heart risks?
- Which breathing setting keeps Kids' lungs healthier during heart surgery?
- Could a simple sleep guide ease insomnia in lung disease?
- Can 3D models bring a Baby's birth defect into focus before birth?
- A Needle-Free heart check? MRI may replace invasive catheterization
- Can a diabetes drug help the lungs? pioglitazone put to the test for pulmonary hypertension